Blend to Limit Oxygen in ECMO: A Randomised Controlled Registry Trial

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 300 participants.

Also called NCT03841084

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 300 participants (enrolled count) (from the registry)
Sponsor
Australian and New Zealand Intensive Care Research Centre (from the registry)
Registry
  • NCT NCT03841084
Other papers using this trial's data
  • Conservative or liberal oxygen targets in patients on venoarterial extracorporeal membrane oxygenation Intensive care medicine, 2024-09 DOI, PubMed 39162827, PMC11377512 PubMed links an erratum for this paper. Erratum: PMID 39412548 In the PMC Open Access subset under CC BY-NC.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Australia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03841084. Randomized; no masking; primary purpose treatment. Start 2019-09-18 (actual); primary completion 2023-06-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Blend to Limit Oxygen in ECMO: A Randomised Controlled Registry Trial
Acronym
BLENDER
Condition
Cardiac Failure
Condition
Critical Illness
Intervention (Drug)
Oxygen
Lead sponsor
Australian and New Zealand Intensive Care Research Centre (class: other)

Record details

Record id
cardio:ct-nct03841084
Content hash
0299a0522fc1761dae645f2ccb6e7e7ad9d7bfe6fb51e6a64324c652d29ec755